CA2418087A1 - Utilisation de sequences d'adn microbiennes pouvant identifier des maladies humaines - Google Patents
Utilisation de sequences d'adn microbiennes pouvant identifier des maladies humaines Download PDFInfo
- Publication number
- CA2418087A1 CA2418087A1 CA002418087A CA2418087A CA2418087A1 CA 2418087 A1 CA2418087 A1 CA 2418087A1 CA 002418087 A CA002418087 A CA 002418087A CA 2418087 A CA2418087 A CA 2418087A CA 2418087 A1 CA2418087 A1 CA 2418087A1
- Authority
- CA
- Canada
- Prior art keywords
- gene
- dna
- mutation
- protein
- anyone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract description 28
- 201000010099 disease Diseases 0.000 title claims abstract description 27
- 230000000813 microbial effect Effects 0.000 title claims abstract description 24
- 108091028043 Nucleic acid sequence Proteins 0.000 title claims abstract description 16
- 241000282414 Homo sapiens Species 0.000 title claims description 59
- 230000007923 virulence factor Effects 0.000 claims abstract description 19
- 239000000304 virulence factor Substances 0.000 claims abstract description 19
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 9
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 claims abstract description 7
- 239000012634 fragment Substances 0.000 claims abstract description 5
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 3
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 3
- 108090000623 proteins and genes Proteins 0.000 claims description 96
- 108020004414 DNA Proteins 0.000 claims description 68
- 230000035772 mutation Effects 0.000 claims description 49
- 201000000980 schizophrenia Diseases 0.000 claims description 30
- 230000014509 gene expression Effects 0.000 claims description 29
- 102000004169 proteins and genes Human genes 0.000 claims description 29
- 241001465754 Metazoa Species 0.000 claims description 24
- 238000000034 method Methods 0.000 claims description 23
- 230000008488 polyadenylation Effects 0.000 claims description 21
- 150000001875 compounds Chemical class 0.000 claims description 18
- 230000009261 transgenic effect Effects 0.000 claims description 18
- 230000000694 effects Effects 0.000 claims description 17
- 108020005345 3' Untranslated Regions Proteins 0.000 claims description 11
- 244000005700 microbiome Species 0.000 claims description 11
- 206010012289 Dementia Diseases 0.000 claims description 10
- 230000033228 biological regulation Effects 0.000 claims description 10
- 238000012216 screening Methods 0.000 claims description 8
- 108090000185 alpha-Synuclein Proteins 0.000 claims description 7
- 239000003814 drug Substances 0.000 claims description 7
- 239000013612 plasmid Substances 0.000 claims description 7
- 208000024827 Alzheimer disease Diseases 0.000 claims description 6
- 101710095339 Apolipoprotein E Proteins 0.000 claims description 6
- 241000589968 Borrelia Species 0.000 claims description 6
- 101710121290 Oligophrenin-1 Proteins 0.000 claims description 6
- 108010036908 Presenilin-2 Proteins 0.000 claims description 6
- 230000002779 inactivation Effects 0.000 claims description 6
- 230000003834 intracellular effect Effects 0.000 claims description 6
- 238000013519 translation Methods 0.000 claims description 6
- 241000218236 Cannabis Species 0.000 claims description 5
- 108010052185 Myotonin-Protein Kinase Proteins 0.000 claims description 5
- 208000018737 Parkinson disease Diseases 0.000 claims description 5
- 210000004369 blood Anatomy 0.000 claims description 5
- 239000008280 blood Substances 0.000 claims description 5
- 210000001519 tissue Anatomy 0.000 claims description 5
- 241000283984 Rodentia Species 0.000 claims description 4
- 230000003542 behavioural effect Effects 0.000 claims description 4
- 229940079593 drug Drugs 0.000 claims description 4
- 241000606161 Chlamydia Species 0.000 claims description 3
- 101710180845 Integral membrane protein 2B Proteins 0.000 claims description 3
- 241000124008 Mammalia Species 0.000 claims description 3
- 208000021642 Muscular disease Diseases 0.000 claims description 3
- 201000009623 Myopathy Diseases 0.000 claims description 3
- 210000000349 chromosome Anatomy 0.000 claims description 3
- 230000005764 inhibitory process Effects 0.000 claims description 3
- 238000012544 monitoring process Methods 0.000 claims description 3
- 230000007119 pathological manifestation Effects 0.000 claims description 3
- 230000001629 suppression Effects 0.000 claims description 3
- 101150070366 2C gene Proteins 0.000 claims description 2
- 241000488157 Escherichia sp. Species 0.000 claims description 2
- 108010076504 Protein Sorting Signals Proteins 0.000 claims description 2
- 241000606701 Rickettsia Species 0.000 claims description 2
- 230000007614 genetic variation Effects 0.000 claims description 2
- 244000052769 pathogen Species 0.000 claims description 2
- 101710187010 Cannabinoid receptor 1 Proteins 0.000 claims 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims 1
- 102100033868 Cannabinoid receptor 1 Human genes 0.000 claims 1
- 241000224016 Plasmodium Species 0.000 claims 1
- 108091036407 Polyadenylation Proteins 0.000 claims 1
- 230000001717 pathogenic effect Effects 0.000 claims 1
- 241000894007 species Species 0.000 claims 1
- 230000001960 triggered effect Effects 0.000 claims 1
- 238000011161 development Methods 0.000 abstract description 6
- 238000010171 animal model Methods 0.000 abstract description 2
- 241000589969 Borreliella burgdorferi Species 0.000 description 41
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 32
- 230000002068 genetic effect Effects 0.000 description 19
- 208000015181 infectious disease Diseases 0.000 description 13
- 230000006798 recombination Effects 0.000 description 13
- 238000005215 recombination Methods 0.000 description 13
- 241000589970 Spirochaetales Species 0.000 description 12
- 239000002773 nucleotide Substances 0.000 description 12
- 125000003729 nucleotide group Chemical group 0.000 description 12
- 230000002458 infectious effect Effects 0.000 description 11
- 238000003780 insertion Methods 0.000 description 11
- 230000037431 insertion Effects 0.000 description 10
- 241000700159 Rattus Species 0.000 description 8
- 241000699666 Mus <mouse, genus> Species 0.000 description 7
- 241000223960 Plasmodium falciparum Species 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 208000016604 Lyme disease Diseases 0.000 description 6
- 238000012546 transfer Methods 0.000 description 6
- 230000005945 translocation Effects 0.000 description 6
- 241000589972 Borrelia sp. Species 0.000 description 5
- 102000012419 Presenilin-2 Human genes 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 241000700157 Rattus norvegicus Species 0.000 description 4
- 102000003802 alpha-Synuclein Human genes 0.000 description 4
- 230000006399 behavior Effects 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 4
- 244000045947 parasite Species 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 230000000698 schizophrenic effect Effects 0.000 description 4
- 229930024421 Adenine Natural products 0.000 description 3
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 3
- 102100029470 Apolipoprotein E Human genes 0.000 description 3
- 101150066912 Cbl gene Proteins 0.000 description 3
- 241001647372 Chlamydia pneumoniae Species 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 241000206602 Eukaryota Species 0.000 description 3
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 3
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 3
- 208000004547 Hallucinations Diseases 0.000 description 3
- 102000018658 Myotonin-Protein Kinase Human genes 0.000 description 3
- 102100035592 Oligophrenin-1 Human genes 0.000 description 3
- 101800001065 Protein 2B Proteins 0.000 description 3
- 229960000643 adenine Drugs 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 238000002744 homologous recombination Methods 0.000 description 3
- 238000011813 knockout mouse model Methods 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 208000023697 ABri amyloidosis Diseases 0.000 description 2
- 108700028369 Alleles Proteins 0.000 description 2
- 208000020925 Bipolar disease Diseases 0.000 description 2
- 208000010482 CADASIL Diseases 0.000 description 2
- 108050007331 Cannabinoid receptor Proteins 0.000 description 2
- 208000033935 Cerebral autosomal dominant arteriopathy-subcortical infarcts-leukoencephalopathy Diseases 0.000 description 2
- 241001647367 Chlamydia muridarum Species 0.000 description 2
- 241001495184 Chlamydia sp. Species 0.000 description 2
- 108091026890 Coding region Proteins 0.000 description 2
- 239000003155 DNA primer Substances 0.000 description 2
- 101150049660 DRD2 gene Proteins 0.000 description 2
- 206010012239 Delusion Diseases 0.000 description 2
- 201000011240 Frontotemporal dementia Diseases 0.000 description 2
- 101000710899 Homo sapiens Cannabinoid receptor 1 Proteins 0.000 description 2
- 201000000162 ITM2B-related cerebral amyloid angiopathy 1 Diseases 0.000 description 2
- 208000009829 Lewy Body Disease Diseases 0.000 description 2
- 201000002832 Lewy body dementia Diseases 0.000 description 2
- 241000699660 Mus musculus Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 108010029756 Notch3 Receptor Proteins 0.000 description 2
- 208000028017 Psychotic disease Diseases 0.000 description 2
- 102000018120 Recombinases Human genes 0.000 description 2
- 108010091086 Recombinases Proteins 0.000 description 2
- 108091036066 Three prime untranslated region Proteins 0.000 description 2
- 208000010206 X-Linked Mental Retardation Diseases 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 208000028683 bipolar I disease Diseases 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 208000011142 cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 Diseases 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 230000001054 cortical effect Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 231100000868 delusion Toxicity 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 229960003638 dopamine Drugs 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 230000037433 frameshift Effects 0.000 description 2
- 210000004602 germ cell Anatomy 0.000 description 2
- 230000006801 homologous recombination Effects 0.000 description 2
- 150000002611 lead compounds Chemical class 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 230000015654 memory Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 230000033607 mismatch repair Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000000869 mutational effect Effects 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 230000002276 neurotropic effect Effects 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 210000003705 ribosome Anatomy 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 230000006886 spatial memory Effects 0.000 description 2
- 208000031906 susceptibility to X-linked 2 autism Diseases 0.000 description 2
- 230000002123 temporal effect Effects 0.000 description 2
- 238000001890 transfection Methods 0.000 description 2
- 230000017105 transposition Effects 0.000 description 2
- 230000003936 working memory Effects 0.000 description 2
- QDZOEBFLNHCSSF-PFFBOGFISA-N (2S)-2-[[(2R)-2-[[(2S)-1-[(2S)-6-amino-2-[[(2S)-1-[(2R)-2-amino-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-N-[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]pentanediamide Chemical compound C([C@@H](C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)NC(=O)[C@@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](N)CCCNC(N)=N)C1=CC=CC=C1 QDZOEBFLNHCSSF-PFFBOGFISA-N 0.000 description 1
- 101150084750 1 gene Proteins 0.000 description 1
- 101710137189 Amyloid-beta A4 protein Proteins 0.000 description 1
- 102100022704 Amyloid-beta precursor protein Human genes 0.000 description 1
- 101710151993 Amyloid-beta precursor protein Proteins 0.000 description 1
- 101710095342 Apolipoprotein B Proteins 0.000 description 1
- 102100040202 Apolipoprotein B-100 Human genes 0.000 description 1
- 108010060159 Apolipoprotein E4 Proteins 0.000 description 1
- 241000238421 Arthropoda Species 0.000 description 1
- 239000005996 Blood meal Substances 0.000 description 1
- 241001148605 Borreliella garinii Species 0.000 description 1
- 102100029895 Bromodomain-containing protein 4 Human genes 0.000 description 1
- 108010073366 CB1 Cannabinoid Receptor Proteins 0.000 description 1
- 102000009132 CB1 Cannabinoid Receptor Human genes 0.000 description 1
- 102000018208 Cannabinoid Receptor Human genes 0.000 description 1
- 206010061041 Chlamydial infection Diseases 0.000 description 1
- 241000282552 Chlorocebus aethiops Species 0.000 description 1
- 108010077544 Chromatin Proteins 0.000 description 1
- 241000193464 Clostridium sp. Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 108010065372 Dynorphins Proteins 0.000 description 1
- 102100025709 Dyslexia-associated protein KIAA0319 Human genes 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000783609 Homo sapiens 5-hydroxytryptamine receptor 1E Proteins 0.000 description 1
- 101000794024 Homo sapiens Bromodomain-containing protein 4 Proteins 0.000 description 1
- 101001056599 Homo sapiens Dyslexia-associated protein KIAA0319 Proteins 0.000 description 1
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 1
- 101000708766 Homo sapiens Structural maintenance of chromosomes protein 3 Proteins 0.000 description 1
- 101000963221 Homo sapiens mRNA guanylyltransferase Proteins 0.000 description 1
- 102100023350 Integral membrane protein 2B Human genes 0.000 description 1
- 102000008133 Iron-Binding Proteins Human genes 0.000 description 1
- 108010035210 Iron-Binding Proteins Proteins 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 241001490312 Lithops pseudotruncatella Species 0.000 description 1
- 241000282560 Macaca mulatta Species 0.000 description 1
- 108700005443 Microbial Genes Proteins 0.000 description 1
- 108010020004 Microtubule-Associated Proteins Proteins 0.000 description 1
- 102000009664 Microtubule-Associated Proteins Human genes 0.000 description 1
- 102100040243 Microtubule-associated protein tau Human genes 0.000 description 1
- 101710115937 Microtubule-associated protein tau Proteins 0.000 description 1
- 241000714177 Murine leukemia virus Species 0.000 description 1
- 206010068871 Myotonic dystrophy Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 102000001760 Notch3 Receptor Human genes 0.000 description 1
- 108010061100 Nucleoproteins Proteins 0.000 description 1
- 102000011931 Nucleoproteins Human genes 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 101150033824 PAA1 gene Proteins 0.000 description 1
- 241000042032 Petrocephalus catostoma Species 0.000 description 1
- 241001442539 Plasmodium sp. Species 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 102100024622 Proenkephalin-B Human genes 0.000 description 1
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 1
- 208000035415 Reinfection Diseases 0.000 description 1
- 241000606697 Rickettsia prowazekii Species 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 102400000096 Substance P Human genes 0.000 description 1
- 101800003906 Substance P Proteins 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- DZHSAHHDTRWUTF-SIQRNXPUSA-N amyloid-beta polypeptide 42 Chemical compound C([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O)[C@@H](C)CC)C(C)C)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(C)C)C1=CC=CC=C1 DZHSAHHDTRWUTF-SIQRNXPUSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940046545 animal allergen extract Drugs 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000007924 bacterial virulence factor Effects 0.000 description 1
- 102000023732 binding proteins Human genes 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000000625 blastula Anatomy 0.000 description 1
- 235000010633 broth Nutrition 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 229930003827 cannabinoid Natural products 0.000 description 1
- 239000003557 cannabinoid Substances 0.000 description 1
- 230000035605 chemotaxis Effects 0.000 description 1
- 201000000902 chlamydia Diseases 0.000 description 1
- 208000012538 chlamydia trachomatis infectious disease Diseases 0.000 description 1
- 210000003483 chromatin Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 108091036078 conserved sequence Proteins 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000034431 double-strand break repair via homologous recombination Effects 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 231100000221 frame shift mutation induction Toxicity 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000008303 genetic mechanism Effects 0.000 description 1
- 230000000971 hippocampal effect Effects 0.000 description 1
- 210000003917 human chromosome Anatomy 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 244000000056 intracellular parasite Species 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000006742 locomotor activity Effects 0.000 description 1
- 230000027928 long-term synaptic potentiation Effects 0.000 description 1
- 102100039604 mRNA guanylyltransferase Human genes 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000001343 mnemonic effect Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 230000017511 neuron migration Effects 0.000 description 1
- 208000002040 neurosyphilis Diseases 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000001830 phrenic effect Effects 0.000 description 1
- 230000003234 polygenic effect Effects 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 229940070376 protein Drugs 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 229940046939 rickettsia prowazekii Drugs 0.000 description 1
- 230000008786 sensory perception of smell Effects 0.000 description 1
- 108010030336 serotonin 1E receptor Proteins 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- XLNZEKHULJKQBA-UHFFFAOYSA-N terbufos Chemical compound CCOP(=S)(OCC)SCSC(C)(C)C XLNZEKHULJKQBA-UHFFFAOYSA-N 0.000 description 1
- 201000006088 tertiary neurosyphilis Diseases 0.000 description 1
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000001296 transplacental effect Effects 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 230000005570 vertical transmission Effects 0.000 description 1
- 229940118696 vibrio cholerae Drugs 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
L'invention concerne l'utilisation de séquences d'ADN comprenant un fragment d'un acide nucléique codant un facteur de virulence microbienne en tant que moyen d'identifier des maladies ou une prédisposition génétique à de telles maladies. Elle concerne également l'utilisation desdites séquences d'ADN pour la mise au point de modèles de maladies animales.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IBPCT/IB00/01127 | 2000-08-16 | ||
| IB0001127 | 2000-08-16 | ||
| PCT/IB2001/000189 WO2002014546A1 (fr) | 2000-08-16 | 2001-02-15 | Utilisation de sequences d'adn microbiennes pouvant identifier des maladies humaines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2418087A1 true CA2418087A1 (fr) | 2002-02-21 |
Family
ID=11003962
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002418087A Abandoned CA2418087A1 (fr) | 2000-08-16 | 2001-02-15 | Utilisation de sequences d'adn microbiennes pouvant identifier des maladies humaines |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1309722A1 (fr) |
| JP (1) | JP2004506429A (fr) |
| AU (1) | AU2001230448A1 (fr) |
| CA (1) | CA2418087A1 (fr) |
| WO (1) | WO2002014546A1 (fr) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5986054A (en) * | 1995-04-28 | 1999-11-16 | The Hospital For Sick Children, Hsc Research And Development Limited Partnership | Genetic sequences and proteins related to alzheimer's disease |
| AU8151898A (en) * | 1997-06-20 | 1999-01-04 | Human Genome Sciences, Inc. | Lyme disease vaccines |
-
2001
- 2001-02-15 WO PCT/IB2001/000189 patent/WO2002014546A1/fr not_active Ceased
- 2001-02-15 EP EP01902591A patent/EP1309722A1/fr not_active Withdrawn
- 2001-02-15 CA CA002418087A patent/CA2418087A1/fr not_active Abandoned
- 2001-02-15 JP JP2002519671A patent/JP2004506429A/ja not_active Withdrawn
- 2001-02-15 AU AU2001230448A patent/AU2001230448A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1309722A1 (fr) | 2003-05-14 |
| JP2004506429A (ja) | 2004-03-04 |
| WO2002014546A1 (fr) | 2002-02-21 |
| AU2001230448A1 (en) | 2002-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ashburner et al. | An exploration of the sequence of a 2.9-Mb region of the genome of Drosophila melanogaster: the Adh region | |
| Shannon et al. | Differential expansion of zinc-finger transcription factor loci in homologous human and mouse gene clusters | |
| Baxter et al. | Linkage mapping and comparative genomics using next-generation RAD sequencing of a non-model organism | |
| De Setta et al. | Building the sugarcane genome for biotechnology and identifying evolutionary trends | |
| Williamson et al. | Identification of mutations in the housefly para-type sodium channel gene associated with knockdown resistance (kdr) to pyrethroid insecticides | |
| Sandkam et al. | Extreme Y chromosome polymorphism corresponds to five male reproductive morphs of a freshwater fish | |
| Frazer et al. | Computational and biological analysis of 680 kb of DNA sequence from the human 5q31 cytokine gene cluster region | |
| Zhang et al. | Genomic insights into mite phylogeny, fitness, development, and reproduction | |
| Li et al. | Pfmrk, a MO15‐related protein kinase from Plasmodium falciparum: gene cloning, sequence, stage‐specific expression and chromosome localization | |
| AU2003245488A8 (en) | Functional sites | |
| Svedberg et al. | Convergent evolution of complex genomic rearrangements in two fungal meiotic drive elements | |
| Moran et al. | Genomic resources for darters (Percidae: Etheostominae) provide insight into postzygotic barriers implicated in speciation | |
| De Carvalho et al. | The wtf meiotic driver gene family has unexpectedly persisted for over 100 million years | |
| Ma et al. | Whole‐genome de novo assemblies reveal extensive structural variations and dynamic organelle‐to‐nucleus DNA transfers in African and Asian rice | |
| Kelly et al. | New kid on the ID block: neural functions of the Nab2/ZC3H14 class of Cys3His tandem zinc-finger polyadenosine RNA binding proteins | |
| Lobo et al. | Genomic analysis in the sting-2 quantitative trait locus for defensive behavior in the honey bee, Apis mellifera | |
| Lipovich et al. | Genomic structure and evolutionary context of the human feline leukemia virus subgroup C receptor (hFLVCR) gene: evidence for block duplications and de novo gene formation within duplicons of the hFLVCR locus | |
| Syrzycka et al. | Genetic and molecular analysis of essential genes in centromeric heterochromatin of the left arm of chromosome 3 in Drosophila melanogaster | |
| Dequen et al. | The Caenorhabditis elegans FancD2 ortholog is required for survival following DNA damage | |
| Rhee et al. | Genomic organization of selected genes in the small monogonont rotifer, Brachionus koreanus | |
| US20040101867A1 (en) | Use of microbial dna sequences for the identification of human diseases | |
| Patel et al. | Globin gene structure in a reptile supports the transpositional model for amniote α-and β-globin gene evolution | |
| Wang et al. | Identification of differentially expressed genes in Oncomelania hupensis chronically infected with Schistosoma japonicum | |
| Bourguet et al. | Major alleles of CDCA7 shape CG methylation in Arabidopsis thaliana | |
| EP1309722A1 (fr) | Utilisation de sequences d'adn microbiennes pouvant identifier des maladies humaines |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Dead |